Aspirin—Not Really for Primary Prevention - Frankly Speaking EP 248Guest: Jill M. Terrien, PhD, ANP-BC
Music Credit: Richard Onorato
Join us to hear a discussion on the important changes the AHA/ACC and USPSTF have made to their positions on the use of aspirin for primary prevention of cardiovascular disease. The organizations note that while aspirin for primary prevention lowers the risk of a myocardial infarction, its harmful effects may outweigh its benefits. Learn the aspirin recommendations for your patients in their 40s, 50s, and 60s who are at higher risk for a cardiovascular event.
Episode Resources and Links:
- New: https://www.uspreventiveservicestaskforce.org/uspstf/draft-recommendation/aspirin-use-to-prevent-cardiovascular-disease-preventive-medication
- Old: https://www.aafp.org/afp/2016/1015/od1.html
Already listened on another platform?
- Review the rationale for aspirin’s role in cardiovascular risk prevention
- Summarize new data discussing risks and benefits of aspirin for primary prevention
Supporters and Partners